A catalyst for asymmetric induction

Abstract: Catalysts for producing optically active cyanohydrins by addition of hydrogen cyanide to aldehydes comprising a titanium (IV) alkoxide and a dipeptide derivative of formula (I) wherein R¹ is isopropyl, isobutyl, sec-butyl, tert-butyl, methyl, benzyl or phenyl, R³ is lower alkoxy, hydroxyl or mono- or di-lower alkylamino, and either R⁴ is hydrogen and R² is benzyl, indol-3-ylmethyl, isopropyl, isobutyl, or phenyl, or R² and R⁴ together form -CH₂-CH=CH- or -CH=CH-CH₂-, R⁵, R⁶, R⁷ and R⁸ are the same or different and each is hydrogen, halogen, lower alkyl or lower alkoxy, or R⁵ and R⁶ or R⁶ and R⁷, or R⁷ and R⁸ together form -CH=CH-CH=CH- or -OCH₂O-, and * denotes an asymmetric carbon atom having an absolute configuration of S or R.

Description: The present invention relates to a catalyst for asymmetric induction. More particularly, it relates to a catalyst useful for preparation of optically active cyanohydrins by addition of hydrogen cyanide to aldehydes. The present inventors have previously reported that (R)-cyanohydrin isomers are obtained by asymmetric addition reaction of hydrogen cyanide to aldehydes with cyclo-[(S)-phenylalanyl-(S)-histidyl] [Inoue et al., J. Chem. Soc., Chem. Comm., 229 (1981): Bull, Chem. Soc. Jpn., 59, 893 (1986)]. For example, (R)-mandelonitrile is obtained at a relatively high purity and in a high yield by allowing benzaldehyde to react with hydrogen cyanide in the presence of cyclo-[(S)-phenylalanyl-(S)-histidyl)]. The present inventors have found a further excellent catalyst for asymmetric induction in the course of research on asymmetric induction catalyzed by dipeptide derivatives. The present invention provides a catalyst for asymmetric induction comprising a titanium (IV) alkoxide and a dipeptide derivative of formula (I) wherein R¹ represents isopropyl, isobutyl, sec-butyl, tert-butyl, methyl, benzyl or phenyl, R² represents benzyl, indol-3-ylmethyl, isopropyl, isobutyl or phenyl, R³ represents lower alkoxy (e.g. C₁₋₄ alkoxy such as methoxy or ethoxy), hydroxyl, or mono- or di-lower alkylamino (e.g. C₁₋₄ alkylamino such as methylamino or ethylamino), R⁴ represents hydrogen, R⁵, R⁶, R⁷ and R⁸ are the same or different and each represents hydrogen, halogen (e.g. fluorine, chlorine or bromine), lower alkyl (e.g. C₁₋₄ alkyl such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl or tert-butyl) or lower alkoxy (e.g. C₁₋₄ alkoxy such as methoxy or ethoxy), or R⁵ and R⁶, R⁶ and R⁷ or R⁷ and R⁸ are bonded together at their terminals to form -CH=CH-CH=CH- or OCH₂O, and * denotes an absolute configuration of S or R. The invention further provides the use of the above catalyst in the preparation of an optically active cyanohydrin, and a process for preparing an optically active cyanohydrin by addition of hydrogen cyanide to an aldehyde in the presence of the above catalyst. Several embodiments of the dipeptide derivatives represented by the formula [I] are given below: wherein R¹, R², R³, R⁴ and * are as defined above. In the dipeptide derivative represented by the formula [I] used for the catalyst of the present invention, as the R¹ substituent, isopropyl, isobutyl, sec-butyl, tert-butyl, methyl and benzyl are preferred. As the R² substituent, benzyl and indol-3-ylmethyl are preferred. As the R³ substituent, lower alkoxy is preferred. Not less than 2 substituents out of R⁵, R⁶, R⁷ and R⁸ are preferably hydrogen. The dipeptide derivative of formula [I] can be prepared, for example, by condensation of a salicyl aldehyde derivative such as 2-hydroxy-1-naphthaldehyde and dipeptides as shown in the following scheme: wherein R¹, R², R³, R⁴, R⁵, R⁶, R⁷, R⁸ and * are the same as those defined above. The dipeptides used for the condensation with the salicyl aldehyde derivative such as 2-hydroxy-1-naphthaldehyde can be prepared according to any of the conventional methods for synthesizing peptides. For example, by the condensation of N-benzyloxycarbonyl-(S)-valine, N-benzyloxycarbonyl-(S)-leucine, N-benzyloxycarbonyl-(S)-isoleucine, N-benzyloxycarbonyl-(S)-tert-leucine, N-benzyloxycarbonyl-(S)-alanine, N-benzyloxycarbonyl-(S)-phenylalanine or the corresponding R-isomers thereof with (S)-phenylalanine alkyl esters or amides such as lower alkyl esters having 1 - 4 carbon atoms (e.g. a methyl ester or an ethyl ester or mono- or di-lower alkylamides (e.g. butylamide or diethylamide), or (S)-tryptophan alkyl esters or amides or R-isomers thereof, in the presence of isobutyl chloroformate by the mixed acid anhydride method, the corresponding dipeptide derivatives such as N-benzyloxycarbonyl-(S)-valyl-(S)-phenylalanine methyl ester can be obtained. The dipeptide derivatives are then subjected to hydrogenolysis in the presence of palladium/carbon and condensation with the salicyl aldehyde derivative such as 2-hydroxy-1-naphthaldehyde. The titanium (IV) alkoxides used as a component of the catalyst are suitably lower alkoxides (e.g. C₁₋₄ alkoxides such as ethoxide, isopropoxide, propoxide and butoxide) of titanium (IV). Examples of the titanium (IV) alkoxide are titanium (IV) tetraethoxide, titanium (IV) tetraisopropoxide, titanium (IV) tetrapropoxide and titanium (IV) tetrabutoxide. The titanium alkoxides are usually used in a molar ratio of 0.5 - 2, preferably 1 - 2 to the compound represented by the formula [I]. It is presumed that the catalyst of the present invention is a complex consisting of the dipeptide derivative and the titanium (IV) alkoxide, although the stereochemistry of the catalyst has not yet been established. The catalyst is very useful as a catalyst for preparing optically active cyanohydrins by addition of hydrogen cyanide to an aldehyde. For example, when the dipeptide derivative Nap-S-Val-S-Phe-OMe, which is the compound represented by formula [II] wherein R¹ is isopropyl, R² is benzyl, R³ is methoxy, R⁴ is hydrogen and all of the absolute configurations are S, and titanium (IV) tetraethoxide are used as the catalyst of the present invention, (R)-mandelonitrile is produced by reaction of benzaldehyde and hydrogen cyanide in the presence of the catalyst. On the other hand, when the dipeptide derivative Nap-R-Val-R-Phe-OMe, which is the compound represented by formula [II] wherein R¹ is isopropyl, R² is benzyl, R₃ is methoxy, R⁴ is hydrogen and all of the absolute configurations are R, and titanium (IV) tetraethoxide are used, (S)-mandelonitrile is produced. Thus, the catalyst of the present invention can be used as a catalyst for preparing a variety of optically active cyanohydrins which are useful as intermediates in the preparation of pharmaceuticals, agrochemicals such as pyrethroid insecticides, perfumes or the like. In the catalyst of the present invention, each amino acid component of the dipeptide derivative represented by the formula [I] preferably has the same configuration; in other words, both absolute configurations relating to the carbon atoms represented by * are S- or R-isomers from the viewpoint of optical yield of the reaction. Substrate compounds on which the catalyst of the present invention works are, in addition to the aforementioned benzaldehyde, aromatic aldehydes such as p-methylbenzaldehyde, m-methoxybenzaldehyde, naphthaldehyde, m-phenoxybenzaldehyde optionally substituted by one to two halogen atoms (e.g., a fluorine atom, a chlorine atom, a bromine atom) and furfural, aliphatic aldehydes such as heptanal, and alicyclic aldehydes such as cyclohexanecarboaldehyde. When the catalyst of the present invention is used for the asymmetric synthesis of optically active cyanohydrins, an amount of 1 - 15% by mole to the aldehyde is enough. The synthesis is usually conducted by allowing an aldehyde to react with hydrogen cyanide whose amount is 1 - 5 moles to the aldehyde, in an inert solvent such as toluene, methylene chloride, ethyl ether or isopropyl ether, at a temperature from -80°C to room temperature, preferably from -50°C to room temperature. After termination of the reaction, the reaction mixture is poured into a dilute hydrochloric acid-methanol solution. After excess hydrogen cyanide is removed under reduced pressure, the solution is subjected to the usual after-treatments to give a desired optically active cyanohydrin. [ Examples ] The present invention is further explained with reference to Examples. Example 1 Nap-S-Val-S-Trp-OMe, which is the compound represented by the formula [II]; R¹, an isopropyl group; R², an indol-3-ylmethyl group; R³, a methoxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers (0.05 mmole) was suspended in 3 ml of toluene at room temperature under an argon atmosphere, and titanium (IV) tetraethoxide (0.05 mmole) was added to the suspension under the same atmosphere as above. After being stirred for 30 minutes, the reaction mixture was cooled to -78°C, and benzaldehyde (0.5 mmole) and hydrogen cyanide (0.75 mmole) were added. The mixture was further stirred at -40°C for 3 hours, and the reaction mixture was poured into a dilute hydrochloric acid-methanol solution. The excessive amount of hydrogen cyanide was removed under reduced pressure, and the mandelonitrile was recovered from the organic layer in 85% yield. The product contained the R- and S-isomers at a ratio of 94 : 6. The yield was calculated from integrating intensities of the ¹H-NMR spectrum, and the ratio of the R-and S-isomers was determined by the integrating intensities of the signals corresponding to the methyne protons on the ¹H-NMR spectrum after the product was converted to the corresponding menthyl carbonate according to the usual method. [Tanaka et al., J. Org. Chem., 55, 181 (1990); Mori et al., Chem. Lett., 1989, 2119]. Example 2 The procedure was conducted in the same manner as in Example 1 except that titanium (IV) tetraisopropoxide (0.05 mmole) was used in place of the titanium (IV) tetraethoxide (0.05 mmole) and that the stirring was continued at -20°C for 2.5 hours in place of -40°C for 3 hours, to give mandelonitrile. Yield: 96%. The product contained the R- and S-isomers at a ratio of 89 : 11. Example 3 The procedure was conducted in the same manner as in Example 1 except that Nap-S-Val-S-Phe-OMe was used in place of the Nap-S-Val-S-Trp-OMe and that the stirring was continued at -40°C for 4 hours in place of -40°C for 3 hours, to give mandelonitrile. Yield: 85%. The product contained the R- and S-isomers at a ratio of 93 : 7. Example 4 The procedure was conducted in the same manner as in Example 3 except that Nap-R-Val-R-Phe-OMe was used in place of the Nap-S-Val-S-Phe-OMe, to give mandelonitrile. Yield: 85%. The product contained the R- and S-isomers at a ratio of 9 : 91. Example 5 The procedure was conducted in the same manner as in Example 2 except that Nap-R-Val-S-Phe-OMe was used in place of the Nap-S-Val-S-Trp-OMe and that the stirring was continued at -20°C for 4 hours in place of -20°C for 2.5 hours, to give mandelonitrile. Yield: 84%. The product contained the R- and S-isomers at a ratio of 31 : 69. Example 6 The procedure was conducted in the same manner as in Example 1 except that 2-naphthaldehyde was used in place of the benzaldenyde, and that the stirring was continued at -40°C for 7.5 hours in place of -40°C for 3 hours, to give α-hydroxy-(2-naphthyl)-acetonitrile. Yield: 88%. The product contained the R- and S-isomers at a ratio of 95 : 5. Example 7 The procedure was conducted in the same manner as in Example 6 except that furfural was used in place of the 2-naphthaldehyde, to give α-hydroxy-furfurylnitrile. Yield: 74%. The product contained the R- and S-isomers at a ratio of 7 : 93. Example 8 The procedure was conducted in the same manner as in Example 1 except that Nap-S-Leu-S-Phe-OMe, i.e., a compound represented by the formula [II]; R¹, an isobutyl group; R², a benzyl group; R³, a methoxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe and that the stirring was continued at -20°C for 4 hours in place of -40°C for 3 hours, to give mandelonitrile. Yield: 93%. The product contained the R- and S-isomers at a ratio of 87.5 : 12.5. Example 9 The procedure was conducted in the same manner as in Example 1 except that the stirring was continued at -20°C for 2.5 hours in place of -40°C for 3 hours, to give mandelmitrile. Yield: 97%. The product contained the R- and S-isomers at a ratio of 91 : 9. Example 10 The procedure was conducted in the same manner as in Example 3 except that the stirring was continued at -20°C for 4 hours in place of -40°C for 4 hours, to give mandelonitrile. Yield: 91%. The product contained the R- and S-isomers at a ratio of 91 : 9. Example 11 The procedure was conducted in the same manner as in Example 2 except that Nap-S-Ile-S-Phe-OMe, i.e., a compound represented by the formula [II]; R¹: a sec. butyl group; R² a benzyl group; R³, a methoxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe, to give mandelonitrile. Yield: 94%. The product contained the R- and S-isomers at a ratio of 86.5 : 13.5. Example 12 The procedure was conducted in the same manner as in Example 2 except that Nap-S-t-Leu-S-Phe-OMe, i.e., a compound represented by the formula [II]; R¹, a tert-butyl group; R², a benzyl group; R³, a methoxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe, that methylene chloride was used in place of the toluene, and that the stirring was continued at -20°C for 4.5 hours in place of -20°C for 2.5 hours, to give mandelonitrile. Yield: 74%. The product contained the R- and S-isomers at a ratio of 90 : 10. Example 13 The procedure was conducted in the same manner as in Example 2 except that Nap-S-Ala-S-Phe-OMe, i.e., a compound represented by the formula [II]; R¹, a methyl group; R², a benzyl group; R³, a methoxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe and that the stirring was continued at -20°C for 4 hours in place of -20°C for 2.5 hours, to give mandelonitrile. Yield: 80%. The product contained the R- and S-isomers at a ratio of 79.5 : 20.5. Example 14 The procedure was conducted in the same manner as in Example 2 except that Nap-S-Phe-S-Phe-OMe, i.e., a compound represented by the formula [II]; R¹, a benzyl group; R², a benzyl group; R³, a methoxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe and that the stirring was continued at -20°C for 7.5 hours in place of -20°C for 2.5 hours, to give mandelonitrile. Yield: 94%. The product contained the R- and S-isomers at a ratio of 83.5 : 16.5. Example 15 The procedure was conducted in the same manner as in Example 2 except that Nap-S-Val-S-Phe-NEt2, i.e., a compound represented by the formula [II]; R¹, an isopropyl group; R², a benzyl group; R³, a diethylamino group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe and that the stirring was continued at -40°C for 3 hours and further at -20°C for 15 hours in place of -20°C for 2.5 hours, to give mandelonitrile. Yield: 88%. The product contained the R- and S-isomers at a ratio of 90 : 10. Example 16 The procedure was conducted in the same manner as in Example 4 except that m-phenoxybenzaldehyde was used in place of the benzaldehyde, and that the stirring was continued at -40°C for 11 hours and further at -20°C for 12 hours in place of -40°C for 4 hours, to give α-hydroxy-m-phenylacetonitrile. Yield: 85%. The product contained the R- and S-isomers at a ratio of 7 : 93. Example 17 The procedure was conducted in the same manner as in Example 3 except that cyclohexanecarboaldehyde was used in place of the benzaldehyde, and that the stirring was continued at -40°C for 1.5 hours in place of -40°C for 4 hours, to give α-hydroxy-cyclohexylacetonitrile. Yield: 99%. The product contained the R- and S-isomers at a ratio of 77 : 23. In this connection, the ratio of the R-and S-isomers was determined by gas chromatography of the corresponding diastereomers, (+)-1-methoxy-1-phenyl-2,2,2-trifluoro-propionic acid ester derived from the product. Example 18 The procedure was conducted in the same manner as in Example 2 except that heptanal was used in place of the benzaldehyde, and that the stirring was continued at -40°C for 1 hour in place of -20°C for 2.5 hours, to give 2-hydroxyoctanenitrile. Yield: 99%. The product contained the R- and S-isomers at a ratio of 67 : 33. In this connection, the ratio of the R-and S-isomers was determined by gas chromatography of the corresponding diastereomers, (+)-1-methoxy-1-phenyl-2,2,2-trifluoro-propionic acid ester derived from the product. Example 19 The procedure was conducted in the same manner as in Example 2 except that Nap-S-Val-S-Phe-OH, i.e., a compound represented by the formula [II]; R¹, an isopropyl group; R², a benzyl group; R³, a hydroxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers, was used in place of the Nap-S-Val-S-Trp-OMe, and that the stirring was continued at -20°C for 3 hours and further at 0°C for 16 hours in place of -20°C for 2.5 hours, to give mandelonitrile. Yield: 93%. The product contained the R- and S-isomers at a ratio of 71 : 29. Example 20 The procedure was conducted in the same manner as in Example 2 except that Nap-S-PhGly-S-Phe-OMe, i.e., a compound represented by the formula [II]; R¹, a phenyl group; R², a benzyl group; R³, a methoxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of Nap-S-Val-S-Trp-OMe, and that the stirring was continued at -20°C for 20 hours in place of -20°C for 2.5 hours, to give mandelonitrile. Yield: 62%. The product contained the R- and S-isomers at a ratio of 62.5 : 37.5. Example 21 The procedure was conducted in the same manner as in Example 2 except that Nap-S-Val-S-PhGly-OMe, i.e., a compound represented by the formula [II]; R¹, an isopropyl group; R², a phenyl group; R³, a methoxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe, and that the stirring was continued at -20°C for 4 hours in place of -20°C for 2.5 hours, to give mandelonitrile. Yield: 86%. The product contained the R- and S-isomers at a ratio of 62 : 38. Example 22 The procedure was conducted in the same manner as in Example 2 except that Nap-S-Val-S-Pro-OEt, i.e., the compound represented by the formula [Ia], was used in place of the Nap-S-Val-S-Trp-OMe and that the stirring was continued at -20°C for 20 hours in place of -20°C for 2.5 hours, to give mandelonitrile. Yield: 74%. The product contained the R- and S-isomers at a ratio of 66.5 : 33.5. Example 23 The procedure was conducted in the same manner as in Example 1 except that the stirring was continued at -60°C for 16 hours in place of -40°C for 3 hours, to give mandelonitrile. Yield: 83%. The product contained the R- and S-isomers at a ratio of 95 : 5. Example 24 The procedure was conducted in the same manner as in Example 3 except that titanium (IV) tetrabutoxide (0.05 mole) was used in place of the titanium (IV) tetraethoxide (0.05 mole) and that the stirring was continued at -20°C for 4 hours in place of -40°C for 4 hours, to give mandelonitrile. Yield: 84%. The product contained the R- and S-isomers at a ratio of 89 : 11. Example 25 The procedure was conducted in the same manner as in Example 1 except that Nap-S-Ile-S-Phe-OMe was used in place of the Nap-S-Val-S-Trp-OMe and that the stirring was continued at -40°C for 4 hours in place of -40°C for 3 hours, to give mandelonitrile. Yield: 85%. The product contained the R- and S-isomers at a ratio of 87.5 : 12.5. Example 26 The procedure was conducted in the same manner as in Example 1 except that Nap-S-Val-S-Val-OMe, i.e., a compound represented by the formula [II]; R¹, an isopropyl group; R², an isopropyl group; R³, a methoxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe and that the stirring was continued at -40°C for 4 hours in place of -40°C for 3 hours, to give mandelonitrile. Yield: 64%. The product contained the R- and S-isomers at a ratio of 93.5 : 6.5. Example 27 The procedure was conducted in the same manner as in Example 1 except that Nap-S-Val-S-Leu-OMe, i.e., a compound represented by the formula [II]; R¹, an isopropyl group; R², an isobutyl group; R³, a methoxy group; R⁴, a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe and that the stirring was continued at -40°C for 4 hours in place of -40°C for 3 hours, to give mandelonitrile. Yield: 72%. The product contained the R- and S-isomers at a ratio of 79.5 : 20.5. Example 28 The procedure was conducted in the same manner as in Example 1 except that m-methoxybenzaldehyde was used in place of the benzyldehyde, and that the stirring was continued at -40°C for 4 hours in place of -40°C for 3 hours, to give α-hydroxy-(m-methoxyphenyl)-acetonitrile. Yield: 80%. The product contained the R- and S-isomers at a ratio of 92.5 : 7.5. Example 29 The procedure was conducted in the same manner as in Example 1 except that Sal-S-Val-S-Trp-OMe, i.e., a compound represented by the formula [I]; R¹, an isopropyl group; R², an indol-3-ylmethyl group; R³, a methoxy group; R⁴, a hydrogen atom; each of R⁵, R⁶, R⁷ and R⁸ is a hydrogen atom; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe, and that the stirring was continued at -40°C for 4 hours in place of -40°C for 3 hours to give mandelonitrile. Yield 83%. The product contained the R- and S-isomers at a ratio of 89.5 : 10.5. Example 30 The procedure was conducted in the same manner as in Example 1 except that Nap'-S-Val-S-Trp-OMe, i.e., a compound represented by the formula [I]; R¹, an isopropyl group; R², an indol-3-ylmethyl group; R³, a methoxy group; R⁴, a hydrogen atom; each of R⁵ and R⁶ is a hydrogen atom; R⁷ and R⁸ are bonded together at their terminals to form CH=CH-CH=CH; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe, and that the stirring was continued at -40°C for 2 hours in place of -40°C for 3 hours to give mandelonitrile. Yield 57%. The product contained the R- and S-isomers at a ratio of 87.5 : 12.5. Example 31 The procedure was conducted in the same manner as in Example 1 except that Sal'-S-Val-S-Phe-OMe, i.e., a compound represented by the formula [I]; R¹, an isopropyl group; R², a benzyl group; R³, a methoxy group; R⁴, a hydrogen atom; each of R⁵, R⁶ and R⁷ is a hydrogen atom; R⁸ is a methoxy group; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe, and that the stirring was continued at -20°C for 4 hours in place of -40°C for 3 hours to give mandelonitrile. Yield 68%. The product contained the R- and S-isomers at a ratio of 74 : 26. Example 32 The procedure was conducted in the same manner as in Example 1 except that Sal''-S-Val-S-Trp-OMe, i.e., a compound represented by the formula [I]; R¹, an isopropyl group; R², an indol-3-ylmethyl group; R³, a methoxy group; R⁴, a hydrogen atom; each of R⁵ and R⁷ is a hydrogen atom; each of R⁶ and R⁸ is a tert-butyl group; all of the absolute configurations thereof being S-isomers was used in place of the Nap-S-Val-S-Trp-OMe, and that the stirring was continued at -20°C for 2.5 hours in place of -40°C for 3 hours to give mandelonitrile. Yield 70%. The product contained the R- and S-isomers at a ratio of 70 : 30. The catalyst of the present invention is useful for preparation of optically active cyanohydrins with a high yield and a high optical purity by an addition of hydrogen chanide to aldehydes.

Claims: A catalyst for asymmetric induction comprising a titanium (IV) alkoxide and a dipeptide derivative of formula (I) wherein R¹ is isopropyl, isobutyl, sec-butyl, tert-butyl, methyl, benzyl or phenyl, R³ is lower alkoxy, hydroxyl or mono- or di-lower alkylamino, R⁴ is hydrogen, R² is benzyl, indol-3-ylmethyl, isopropyl, isobutyl, or phenyl, R⁵, R⁶, R⁷, and R⁸ are the same or different and each is hydrogen, halogen, lower alkyl or lower alkoxy, or R⁵ and R⁶ or R⁶ and R⁷ or R⁷ and R⁸ together form -CH=CH-CH=CH- or -OCH₂O-, and * denotes an asymmetric carbon atom having an absolute configuration of S or R. A catalyst according to claim 1 wherein R⁵ and R⁶ together form -CH=CH-CH=CH-, and R⁷ and R⁸ are both hydrogen. A catalyst according to claim 2 wherein R² is benzyl, indol-3-ylmethyl or phenyl. A catalyst according to claim 2 wherein R¹ is isopropyl, isobutyl, sec-butyl, tert-butyl, methyl or benzyl, and R² is benzyl or indol-3-ylmethyl. A catalyst according to any one of the preceding claims wherein both asymmetric carbon atoms have the S absolute configuration. A catalyst according to any one of claims 1 to 4 wherein both asymmetric carbon atoms have the R absolute configuration. A catalyst for asymmetric induction comprising a titanium (IV) alkoxide and a dipeptide derivative of formula (Ia) wherein R¹ is isopropyl, R² and R⁴ together form -CH₂CH₂CH₂-, R³ is an ethoxy group, R⁵ and R⁶ together form -CH=CH-CH=CH-, R⁷ and R⁸ are both hydrogen, and * denotes an asymmetric carbon atom having an absolute configuration of S. A catalyst according to any one of the preceding claims wherein the titanium (IV) alkoxide is used in a molar ratio of 0.5 to 2 to the dipeptide derivative. Use of a catalyst according to any one of claims 1 to 8 in the preparation of an optically active cyanohydrin. Use according to claim 9 in the preparation of an optically active cyanohydrin by an addition of hydrogen cyanide to an aldehyde. Use according to claim 10 wherein the aldehyde is an aromatic aldehyde. Use according to claim 11 wherein the aldehyde is benzaldehyde. Use according to claim 11 wherein the aldehyde is m-phenoxybenzaldehyde or m-phenoxybenzaldehyde substituted by one to two halogen atoms. A process of producing a cyanohydrin comprising adding hydrogen cyanide to an aldehyde in the presence of a catalyst according to any one of claims 1 to 8.

Inventors: INOUE SHOHEI, MORI ATSUNORI, INOUE, SHOHEI, MORI, ATSUNORI
Applicants: SUMITOMO CHEMICAL CO, SUMITOMO CHEMICAL COMPANY, LIMITED
Application year: 1992
Main classification: B01J31
IPC codes: C07C255, B01J31, C07C253